首页> 美国卫生研究院文献>Annals of the American Thoracic Society >Stem Cells Cell Therapies and Bioengineering in Lung Biology and Diseases. Comprehensive Review of the Recent Literature 2010–2012
【2h】

Stem Cells Cell Therapies and Bioengineering in Lung Biology and Diseases. Comprehensive Review of the Recent Literature 2010–2012

机译:肺生物学和疾病中的干细胞细胞疗法和生物工程。近期文献综述(2010-2012)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A conference, “Stem Cells and Cell Therapies in Lung Biology and Lung Diseases,” was held July 25 to 28, 2011 at the University of Vermont to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are rapidly expanding areas of study that provide further insight into and challenge traditional views of mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, to discuss and debate current controversies, and to identify future research directions and opportunities for basic and translational research in cell-based therapies for lung diseases. The goal of this article, which accompanies the formal conference report, is to provide a comprehensive review of the published literature in lung regenerative medicine from the last conference report through December 2012.
机译:2011年7月25日至28日,在佛蒙特大学举行了题为“干细胞和细胞疗法在肺生物学和肺疾病中的应用”的会议,回顾了目前对干细胞和祖细胞在损伤后肺修复中的作用的理解,以及回顾了细胞疗法的现状以及用于肺部疾病的离体生物工程方法。这些是正在迅速扩展的研究领域,可提供进一步的洞察力,并挑战传统的关于几种肺部疾病的损伤和发病机理后肺修复机制的观点。会议的目的是总结该领域的现状,讨论和辩论当前的争议,并确定未来的研究方向以及基于细胞的肺部疾病治疗的基础和转化研究的机会。本文的目的是,在正式会议报告的同时,对从上一次会议报告到2012年12月发表的有关肺再生医学的文献进行全面回顾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号